Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul 17;11(7):417.
doi: 10.3390/toxins11070417.

Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines

Kevin Markey  1 , Catpagavalli Asokanathan  2 , Ian Feavers  2
Affiliations
Review

Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines

Kevin Markey et al. Toxins (Basel). .

Abstract

Whooping cough is caused by the bacterium Bordetella pertussis. There are currently two types of vaccines that can prevent the disease; whole cell vaccines (WCV) and acellular vaccines (ACV). The main virulence factor produced by the organism is pertussis toxin (PTx). This toxin is responsible for many physiological effects on the host, but it is also immunogenic and in its detoxified form is the main component of all ACVs. In producing toxoid for vaccines, it is vital to achieve a balance between sufficiently detoxifying PTx to render it safe while maintaining enough molecular structure that it retains its protective immunogenicity. To ensure that the first part of this balancing act has been successfully achieved, assays are required to accurately measure residual PTx activity in ACV products accurately. Quality control assays are also required to ensure that the detoxification procedures are robust and stable. This manuscript reviews the methods that have been used to achieve this aim, or may have the potential to replace them, and highlights their continuing requirement as vaccines that induce a longer lasting immunity are developed to prevent the re-occurrence of outbreaks that have been observed recently.

Keywords: CHO cell clustering assay; acellular pertussis vaccine; histamine sensitization test; in vitro alternative methods; pertussis toxin; vaccine safety.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Melvin J.A., Scheller E.V., Miller J.F., Cotter P.A. Bordetella pertussis pathogenesis: Current and future challenges. Nat. Rev. Microbiol. 2014;12:274–288. doi: 10.1038/nrmicro3235. - DOI - PMC - PubMed
    1. Pertussis vaccines: WHO position paper. Wkly. Epidemiol. Rec. 2010;85:385–400. - PubMed
    1. Dorji D., Mooi F., Yantorno O., Deora R., Graham R.M., Mukkur T.K. Bordetella pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance. Med. Microbiol. Immunol. 2017;207:3–26. doi: 10.1007/s00430-017-0524-z. - DOI - PubMed
    1. Corbel M.J., Xing D.K. Toxicity and potency evaluation of pertussis vaccines. Expert Rev. Vaccines. 2004;3:89–101. doi: 10.1586/14760584.3.1.89. - DOI - PubMed
    1. Higgs R., Higgins S.C., Ross P.J., Mills K.H. Immunity to the respiratory pathogen Bordetella pertussis. Mucosal Immunol. 2012;5:485–500. doi: 10.1038/mi.2012.54. - DOI - PubMed

LinkOut - more resources